Discover 491 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 491
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: Providence RI, Philadelphia PA, Columbus OH, Wichita KS,
Sponsor: Rhode Island Hospital
Sex: All
Age: 18+
Code: NCT00295906
Recruiting
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Providence RI, New Haven CT, Albany NY, Lebanon NH,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase 1, Phase 2, Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, New York NY, Fairfax VA, Toronto,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05765851
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Providence RI, Boston MA, New York NY, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Providence RI, Boston MA, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Providence RI, Boston MA, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 1 - 39
Code: NCT05999994
Phase 2, Recruiting
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 21+
Code: NCT06480227
Recruiting
Accelerometer Measured Early Recovery After Prolapse Surgery
for
Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP),
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 18 - 70+
Code: NCT07218016
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)